Intraoperative Allogeneic Blood Transfusion Has No Impact on Postoperative Short-Term Outcomes After Pancreatoduodenectomy for Periampullary Malignancies: A Propensity Score Matching Analysis and Mediation Analysis

<b>Background/Objectives</b>: The aim of this study was to investigate the association between intraoperative blood transfusion (BT) and the short-term outcomes of pancreatoduodenectomy (PD) for patients with periampullary malignancies. <b>Methods</b>: In a retrospective two-center cohort analysis, we utilized a logistic and mixed-effects ordinal regression, nonparametric partial correlation, and mediation analysis, complemented by propensity score matching (PSM) and weighting. <b>Results</b>: A total of 491 patients were included. Of these, 18 (3.7%) received an intraoperative BT. An intraoperative BT was associated with blood loss (odds ratio (OR) per 100 mL = 1.42; 95% CI 1.27 to 1.62; <i>p</i> < 0.001) and relatively high ASA classes (OR = 3.75; 95% CI 1.05 to 17.74; <i>p</i> = 0.041). Intraoperative blood loss (r = 0.27; <i>p</i> < 0.001) but not intraoperative BT (r = 0.015; <i>p</i> = 0.698) was associated with postoperative complications. Intraoperative BT was associated with postoperative complications according to the unadjusted regression (OR = 1.95; 95% CI 1.38-2.42, <i>p</i> < 0.001) but not the multivariable ordinal regression. In the mediation analysis for relative risk (RR), intraoperative BT was beneficial (RR = 0.51; 95% CI: 0.01-0.78), and blood loss (RR = 2.49; 95% CI: 1.75-177.34) contributed to the occurrence of major postoperative complications. After PSM, analyses revealed that an intraoperative BT did not have a significant impact on the rates of postoperative major complications (OR = 1.048; <i>p</i> = 0.919), clinically relevant postoperative pancreatic fistula (OR = 0.573; <i>p</i> = 0.439) or postoperative 90-day mortality (OR = 0.714; <i>p</i> = 0.439). <b>Conclusions</b>: When adjusting for intraoperative blood loss, intraoperative BT is not associated with postoperative complications.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2024-10-18
DOI
https://doi.org/10.3390/cancers16203531
Citations
1
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.28
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intraoperative Allogeneic Blood Transfusion Has No Impact on Postoperative Short-Term Outcomes After Pancreatoduodenectomy for Periampullary Malignancies: A Propensity Score Matching Analysis and Mediation Analysis

Thomas Steffen, Kristjan Ukegjini, René Warschkow, Ignazio Tarantino et al.
1 citations
Cancers
Pancreatic and Hepatic Oncology Research
0.28
article

Intraoperative Allogeneic Blood Transfusion Has No Impact on Postoperative Short-Term Outcomes After Pancreatoduodenectomy for Periampullary Malignancies: A Propensity Score Matching Analysis and Mediation Analysis

Thomas Steffen, Kristjan Ukegjini, René Warschkow, Ignazio Tarantino, José Oberholzer, Henrik Petrowsky, Philip C. Müller, Bruno M. Schmied, Jan Philipp Jonas
article en
1 citations

Abstract

<b>Background/Objectives</b>: The aim of this study was to investigate the association between intraoperative blood transfusion (BT) and the short-term outcomes of pancreatoduodenectomy (PD) for patients with periampullary malignancies. <b>Methods</b>: In a retrospective two-center cohort analysis, we utilized a logistic and mixed-effects ordinal regression, nonparametric partial correlation, and mediation analysis, complemented by propensity score matching (PSM) and weighting. <b>Results</b>: A total of 491 patients were included. Of these, 18 (3.7%) received an intraoperative BT. An intraoperative BT was associated with blood loss (odds ratio (OR) per 100 mL = 1.42; 95% CI 1.27 to 1.62; <i>p</i> < 0.001) and relatively high ASA classes (OR = 3.75; 95% CI 1.05 to 17.74; <i>p</i> = 0.041). Intraoperative blood loss (r = 0.27; <i>p</i> < 0.001) but not intraoperative BT (r = 0.015; <i>p</i> = 0.698) was associated with postoperative complications. Intraoperative BT was associated with postoperative complications according to the unadjusted regression (OR = 1.95; 95% CI 1.38-2.42, <i>p</i> < 0.001) but not the multivariable ordinal regression. In the mediation analysis for relative risk (RR), intraoperative BT was beneficial (RR = 0.51; 95% CI: 0.01-0.78), and blood loss (RR = 2.49; 95% CI: 1.75-177.34) contributed to the occurrence of major postoperative complications. After PSM, analyses revealed that an intraoperative BT did not have a significant impact on the rates of postoperative major complications (OR = 1.048; <i>p</i> = 0.919), clinically relevant postoperative pancreatic fistula (OR = 0.573; <i>p</i> = 0.439) or postoperative 90-day mortality (OR = 0.714; <i>p</i> = 0.439). <b>Conclusions</b>: When adjusting for intraoperative blood loss, intraoperative BT is not associated with postoperative complications.

CancersVol. 16(20)
Kantonsspital St. Gallen (CH), University Hospital of Zurich (CH)
Openalex Percentile: Top 35%
Pancreatic and Hepatic Oncology Research
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.